Science Explorer Interactive view Map

Gilead Sciences (United Kingdom)

Research works
114
▲ 68% vs 2013–17
Citations
1.3k
11.3 per fractional work
Top-10% rate
10.3%
record average 16.5%
Open access
55%
world 28%

Not ranked overall: Gilead Sciences (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.06× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.01× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 6.25× its world share, 3 worksImmunology and Micro…Neuroscience: 0.40× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.58× its world share, 1 worksPharmacology, Toxico…Computer Science: 0.65× its world share, 3 worksComputer ScienceEngineering: 0.05× its world share, 0 worksEngineeringEnvironmental Science: 0.10× its world share, 0 worksEnvironmental ScienceMathematics: 0.46× its world share, 0 worksMathematicsPhysics and Astronomy: 0.09× its world share, 0 worksPhysics and AstronomyHealth Professions: 1.03× its world share, 1 worksHealth ProfessionsMedicine: 3.17× its world share, 31 worksMedicineNursing: 0.11× its world share, 0 worksNursingVeterinary: 1.49× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.30× its world share, 0 worksBusiness, Management…Decision Sciences: 1.58× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 3.42× its world share, 4 worksEconomics, Econometr…Psychology: 0.70× its world share, 1 worksPsychologySocial Sciences: 0.17× its world share, 1 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.6×. Every wedge is a field page.

Which keywords describe research at Gilead Sciences (United Kingdom)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Lymphoma, Antiretroviral Therapy, Immune Response, Cancer Immunotherapy, Immunotherapy, CAR T Cells, Chimeric Antigen Receptor and Epidemiology.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology5▲ 2.5×21 topics
  2. Lymphoma5▲ 57×2 topics
  3. Antiretroviral Therapy4▲ 53×5 topics
  4. Immune Response4▲ 14×7 topics
  5. Cancer Immunotherapy4▲ 51×3 topics
  6. Immunotherapy4▲ 11×4 topics
  7. CAR T Cells4▲ 97×1 topic
  8. Chimeric Antigen Receptor4▲ 97×1 topic
  9. Antiviral Therapy3▲ 57×3 topics
  10. Liver Disease3▲ 56×2 topics
  11. HIV Infection2▲ 47×2 topics
  12. Metastatic Breast Cancer2▲ 80×2 topics
  13. Treatment2▲ 3.7×7 topics
  14. Genetic Variation2▲ 19×3 topics
  15. Prognostic Factors2▲ 8.8×5 topics
  16. Breast Cancer2▲ 15×3 topics
  17. Hepatitis C Virus2▲ 102×1 topic
  18. Ribavirin2▲ 102×1 topic
  19. Anomaly Detection2▲ 11×2 topics
  20. Clinical Trials2▲ 4.9×6 topics
  21. Insulin Resistance2▲ 7.3×2 topics
  22. Monoclonal Antibodies2▲ 37×3 topics
  23. Mortality Rates2▲ 33×2 topics
  24. Biopharmaceuticals2▲ 56×2 topics
  25. Cybersecurity2▲ 12×2 topics
  26. Drug Resistance2▲ 11×2 topics
  27. Hepatocellular Carcinoma2▲ 14×3 topics
  28. Immunogenicity2▲ 67×2 topics
  29. HIV1▲ 33×3 topics
  30. HIV/AIDS1▲ 42×3 topics
  31. Rituximab1▲ 18×3 topics
  32. Viral Load1▲ 35×2 topics
  33. HIV Transmission1▲ 35×1 topic
  34. Hepatotoxicity1▲ 53×2 topics
  35. Integrase Inhibitors1▲ 121×1 topic
  36. Intrusion Detection1▲ 18×1 topic
  37. Network Security1▲ 20×1 topic
  38. Neurotoxicity1▲ 21×2 topics
  39. Nucleoside Analogues1▲ 121×1 topic
  40. Preexposure Prophylaxis1▲ 53×1 topic

Which research topics does Gilead Sciences (United Kingdom) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Hepatitis C virus research, HIV/AIDS drug development and treatment and Biosimilars and Bioanalytical Methods.

  1. 1 CAR-T cell therapy research Oncology 4 works
  2. 2 Hepatitis C virus research Hepatology 2 works
  3. 3 HIV/AIDS drug development and treatment Infectious Diseases 1 works
  4. 4 Biosimilars and Bioanalytical Methods Immunology 1 works
  5. 5 Network Security and Intrusion Detection Computer Networks and Communications 1 works
  6. 6 HIV/AIDS Research and Interventions Infectious Diseases 1 works
  7. 7 HIV-related health complications and treatments Emergency Medicine 1 works
  8. 8 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  9. 9 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  10. 10 Cancer Treatment and Pharmacology Oncology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.6%not open45.4%

World: 28% of research is openly available.

with international co-authors69.4%domestic only30.6%

World: 19% is written across borders.

How has Gilead Sciences (United Kingdom)'s research output changed?

Output in 2018–2022 was 68% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.